ArticleMolecules (Basel, Switzerland)2022

Developing CRISPR/Cas9-Mediated Fluorescent Reporter Human Pluripotent Stem-Cell Lines for High-Content Screening.

Kinga Vojnits et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.